Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

2 terminated/withdrawn out of 12 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
10(90.9%)
Phase 3
1(9.1%)
11Total
N/A(10)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT01842204Not ApplicableCompleted

Evaluation of the Efficacy of Electromagnetic Therapy on Postoperative Surgical Pain After Uni- and Bilateral Inguinal Hernia Repair.

Role: collaborator

NCT02376946Not ApplicableTerminated

Third Molar Extraction and Pulsed Electromagnetic FieldTherapy

Role: collaborator

NCT03542955Not ApplicableCompleted

Pulse Shortwave Therapy in Cervical Osteoarthritis

Role: lead

NCT03828864Not ApplicableUnknown

Pulsed Shortwave Therapy (ActiPatch®) Study in Chronic Low Back Pain

Role: lead

NCT02974023Withdrawn

Efficacy of "Pain Gear" in Patients With Chronic Musculoskeletal Pain

Role: collaborator

NCT03166046Not ApplicableCompleted

Migraine Prevention Using ActiPatch

Role: lead

NCT03240146Not ApplicableCompleted

Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain

Role: lead

NCT03604068Not ApplicableUnknown

Pulsed Short Wave Therapy In Cesarean Section

Role: lead

NCT03394547Not ApplicableUnknown

Pulsed Electromagnetic Field Treatment for Painful Periods

Role: collaborator

NCT03395444Not ApplicableUnknown

Pulsed Shortwave Therapy Adjunct Pain and Recovery in Total Knee Replacement

Role: lead

NCT01154010Not ApplicableCompleted

PEMF: an Adjunct Therapy for Anterior Uveitis

Role: collaborator

NCT01431066Phase 3Completed

ActiPatch Plantar Fasciitis Clinical Trial

Role: collaborator

All 12 trials loaded